1. Stocks
  2. Titan Biotech Ltd.
  3. Swot
swot-logo

Titan Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Titan Biotech Ltd. has 6 Strengths, 17 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Companies with Low Debt

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Slowing Down Stocks (DVM)

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Declining Revenue every quarter for the past 2 quarters

Declining Net Cash Flow : Companies not able to generate net cash

Fall in Quarterly Revenue and Net Profit (YoY)

Weak Momentum: Price below Short, Medium and Long Term Averages

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

RSI indicating price weakness

Highest fall from 52 Week High

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Rising Delivery Percentage Compared to Prev Day

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Declining Net Cash Flow and Cash from Operating Activity for last 2 years

Decline in Net Profit with falling Profit Margin (QoQ)